Pulse Biosciences Inc 6L8
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €43.40
- Day Range
- €44.20–44.20
- 52-Week Range
- —–48.40
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 71.32M
- Market Cap
- $3.15B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2,962.89
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 116
- Website
- https://www.pulsebiosciences.com
Valuation
|
Metric
|
6L8
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 35.91 |
Price/Sales | 2,962.89 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
6L8
|
|---|---|
Quick Ratio | 9.27 |
Current Ratio | 9.63 |
Interest Coverage | — |
Quick Ratio
6L8
Profitability
|
Metric
|
6L8
|
|---|---|
Return on Assets (Normalized) | −59.11% |
Return on Equity (Normalized) | −69.38% |
Return on Invested Capital (Normalized) | −67.10% |
Return on Assets
6L8
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|&rgl&#H^ | LOCK|@>$ | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|$$ | LOCK|>Ytm | $50B | |||
| ResMed Inc
RMD
| LOCK|%pr<vc^ | LOCK|KW@? | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|$>P<?# | LOCK|yl@Fh | $32B | |||
| Alcon Inc
ALC
| LOCK|D%Xy#@ | LOCK|@^<#D | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|JGBTtlg | LOCK|sG# | $26B | |||
| Solventum Corp
SOLV
| LOCK|$#>XY%X | LOCK|%s | $15B | |||
| Baxter International Inc
BAX
| LOCK|gR | LOCK|t#yyw | $13B | |||
| Repligen Corp
RGEN
| LOCK|d&!z!!< | LOCK|>@r& | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|pSg!!p | LOCK|@FG@C | $10B |
United States